Medipharm Labs and Cronos Group Sign Second Manufacturing Agreement
Medipharm Labs (TSX: LABS) and Cronos Group (TSX: CRON) (NASDAQ: CRON) have entered into their second manufacturing agreement of the
Read more
Cronos Group
Did Cronos Group Management Personally Benefit from the Redwood Acquisition?
This morning, Twitter user @xb0y posted findings related to a potentially undisclosed insider transaction related to Cronos Group (TSX: CRON)
Read more
Cronos Group Reports Revenues of $10.2 Million For Second Quarter
Cronos Group (TSX: CRON) (NASDAQ: CRON) announced its second quarter financials this morning, reporting net revenues of $10.2 million and
Read more